All you need to know about Gefitinib


If we talk about cancer, then in cancer certain cells in the body grow and multiply in an out of control way.

Anti-cancer medicines, which can be also addressed as chemotherapy, work by inhibiting the way cells grow and increase in number. Gefitinib mainly belongs to a group of anti-cancer (chemotherapy) medicines known as tyrosine kinase inhibitors. These anti-cancer medications effectfully work by blocking chemical messengers, called tyrosine kinases, which is effective as well as helpful in sending signals to cells to grow. This helps in order to stop cancerous cells from growing and spreading.

Gefitinib is the first-line metastatic non-small cell lung cancer medication (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

Side effects of Gefitinib:

Sometimes Gefitinib 250 mg tablets may leave some adverse effects on patients who are taking this medication.

Some rarest, as well as common side effects of gefitinib 250 mg, may include diarrhoea, nausea, vomiting, anorexia, stomatitis, dehydration, skin reactions, paronychia, asymptomatic elevations of liver enzymes, asthenia, conjunctivitis, and blepharitis.

Dose of Gefitinib:

The recommended dose of Gefitinib is 250 mg, which should be taken by mouth once daily with or without food until disease progression or unacceptable toxicity.
Never receive a missed dose within 12 hours of the next dose.

What dosage forms Gefitinib comes in:

Gefitinib is basically an oral tablet and each tablet contains 250 mg gefitinib. Iressa (Gefitinib) comes in the blister packs of 30 tablets.

How Gefitinib Works:

This medication (Gefitinib) mainly inhibits the intracellular phosphorylation of numerous tyrosine kinases associated with transmembrane cell surface receptors, including the tyrosine kinases associated with the epidermal growth factor receptor (EGFR-TK). Epidermal growth factor receptors (EGFR) is expressed on the cell surface of many normal cells and cancer cells.

Interactions with Gefitinib:

Please inform your healthcare if you are receiving or have consumed any medications (including medications consumed some time ago), even those available over the counter. 
Your healthcare professional especially needs to know if:
  • You consume any of the following drugs: carbamazepine, rifampicin, phenytoin, barbiturates, St John’s Wort, ketoconazole, protease inhibitors (drugs to treat HIV/AIDS), itraconazole or macrolide antibiotics such as clarithromycin or erythromycin. These medications can affect the way gefitinib works. Your healthcare provider should also know if you take grapefruit juice. 
  • You receive warfarin (in order to prevent the blood-clots), as gefitinib can affect it. Your healthcare provider may need to check your blood more often. 
  • You consume any drugs which are used in order to help in reducing the stomach acid (e.g. sodium bicarbonate, proton-pump inhibitors, ranitidine).

Serious Warnings and Precautions:

  • Gefitinib must be prescribed by a healthcare provider experienced in treating and managing patients with cancer.
  • It should be avoided in patients with the EGFR mutation negative tumours.
  • Gefitinib has not been studied in patients with the severely reduced kidney function.
  • The isolated cases of liver failure have occured in patients receiving this medication, and a few patients have died from this.
  • Gastrointestinal perforation, including fatal cases, was reported in patients consuming Gefitinib.

Gefitinib Lung Cancer Survival:

The role of gefitinib medication for the treatment of advanced non-small cell lung cancer (NSCLC) is rapidly evolving.

In order to Non-Small Cell Lung Cancer survivors, patients who were receiving gefitinib had an excellent long-term safety profile.

Although it can be specified that most of these patients' tumors harbor EGFR mutations, molecular studies of available tumor specimens are planned to uncover the features that predict long-term survival

How to Store: It should be stored at room temperature, 15 to 30°C.
Keep this drug in the original package in order to protect it from moisture.

Important Information: Females who are carrying the potential to become pregnant should use an effective method of birth control while on the treatment with gefitinib and for at least 2 weeks after the last dose of gefitinib. You should avoid becoming pregnant during treatment with this lung cancer medicine.

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found ...
Read more

Lenvatinib Medication Guide

Lenvatinib is recommended for treating patients with locally recurrent, progressive, metastatic, radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC), together with everolimus for advanced renal cell carcinoma and for hepatocellular carcinoma.  Here are a few important points for patients before taking Lenvatinib:- Female patients who are able to become pregnant must use an effective method of birth control while on the treatment with lenvatinib and for at least 2 weeks after its last dose. Discuss with your doctor about the birth control methods you can use during this time. Lenvatinib is taken at the same time each and every day. If a patient misses any dose, and it cannot be consumed within 12 hours, then that dose must be skipped and the next dose should be consumed at the usual time of administration. The recommended dose is lenvatinib 24 mg (two lenvatinib 10 mg capsules and one lenvatinib 4 mg capsule) orally, taken once in a day, either with or...
Read more

Difference Between Multiple Myeloma And Leukemia

Image
What is multiple myeloma:  This is also known as plasma cell myeloma or Kahler's disease. It is a cancer in plasma cells that typically produce antibodies. When there is only one tumor present it is called as plasmacytoma and when more than one then called as multiple myeloma. The main cause of myeloma is unknown but the major risk factors are obesity,  inheritance chemicals, radiation, etc. With the effect of cancer, there is an abnormality in plasma cells that produces abnormal antibodies that can cause kidney problems. At the initial stage, there is no sign and symptoms but with the advancement of time bone pain, bleeding, anemia and frequent infections are the common symptoms. Multiple myeloma is diagnosed with the help of blood or urine tests or bone marrow biopsy. And the medication of multiple myeloma includes: Chemotherapy- There are several drugs that are used in the treatment of multiple myeloma such as doxorubicin, etoposide, cisplatin, cyclophosphami...
Read more